Cargando…

Proteomic and Metabolomic Analyses of Vanishing White Matter Mouse Astrocytes Reveal Deregulation of ER Functions

Vanishing white matter (VWM) is a leukodystrophy with predominantly early-childhood onset. Affected children display various neurological signs, including ataxia and spasticity, and die early. VWM patients have bi-allelic mutations in any of the five genes encoding the subunits of the eukaryotic tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Wisse, Lisanne E., Penning, Renske, Zaal, Esther A., van Berkel, Carola G. M., ter Braak, Timo J., Polder, Emiel, Kenney, Justin W., Proud, Christopher G., Berkers, Celia R., Altelaar, Maarten A. F., Speijer, Dave, van der Knaap, Marjo S., Abbink, Truus E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770689/
https://www.ncbi.nlm.nih.gov/pubmed/29375313
http://dx.doi.org/10.3389/fncel.2017.00411
_version_ 1783293122718990336
author Wisse, Lisanne E.
Penning, Renske
Zaal, Esther A.
van Berkel, Carola G. M.
ter Braak, Timo J.
Polder, Emiel
Kenney, Justin W.
Proud, Christopher G.
Berkers, Celia R.
Altelaar, Maarten A. F.
Speijer, Dave
van der Knaap, Marjo S.
Abbink, Truus E. M.
author_facet Wisse, Lisanne E.
Penning, Renske
Zaal, Esther A.
van Berkel, Carola G. M.
ter Braak, Timo J.
Polder, Emiel
Kenney, Justin W.
Proud, Christopher G.
Berkers, Celia R.
Altelaar, Maarten A. F.
Speijer, Dave
van der Knaap, Marjo S.
Abbink, Truus E. M.
author_sort Wisse, Lisanne E.
collection PubMed
description Vanishing white matter (VWM) is a leukodystrophy with predominantly early-childhood onset. Affected children display various neurological signs, including ataxia and spasticity, and die early. VWM patients have bi-allelic mutations in any of the five genes encoding the subunits of the eukaryotic translation factor 2B (eIF2B). eIF2B regulates protein synthesis rates under basal and cellular stress conditions. The underlying molecular mechanism of how mutations in eIF2B result in VWM is unknown. Previous studies suggest that brain white matter astrocytes are primarily affected in VWM. We hypothesized that the translation rate of certain astrocytic mRNAs is affected by the mutations, resulting in astrocytic dysfunction. Here we subjected primary astrocyte cultures of wild type (wt) and VWM (2b5(ho)) mice to pulsed labeling proteomics based on stable isotope labeling with amino acids in cell culture (SILAC) with an L-azidohomoalanine (AHA) pulse to select newly synthesized proteins. AHA was incorporated into newly synthesized proteins in wt and 2b5(ho) astrocytes with similar efficiency, without affecting cell viability. We quantified proteins synthesized in astrocytes of wt and 2b5(ho) mice. This proteomic profiling identified a total of 80 proteins that were regulated by the eIF2B mutation. We confirmed increased expression of PROS1 in 2b5(ho) astrocytes and brain. A DAVID enrichment analysis showed that approximately 50% of the eIF2B-regulated proteins used the secretory pathway. A small-scale metabolic screen further highlighted a significant change in the metabolite 6-phospho-gluconate, indicative of an altered flux through the pentose phosphate pathway (PPP). Some of the proteins migrating through the secretory pathway undergo oxidative folding reactions in the endoplasmic reticulum (ER), which produces reactive oxygen species (ROS). The PPP produces NADPH to remove ROS. The proteomic and metabolomics data together suggest a deregulation of ER function in 2b5(ho) mouse astrocytes.
format Online
Article
Text
id pubmed-5770689
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57706892018-01-26 Proteomic and Metabolomic Analyses of Vanishing White Matter Mouse Astrocytes Reveal Deregulation of ER Functions Wisse, Lisanne E. Penning, Renske Zaal, Esther A. van Berkel, Carola G. M. ter Braak, Timo J. Polder, Emiel Kenney, Justin W. Proud, Christopher G. Berkers, Celia R. Altelaar, Maarten A. F. Speijer, Dave van der Knaap, Marjo S. Abbink, Truus E. M. Front Cell Neurosci Neuroscience Vanishing white matter (VWM) is a leukodystrophy with predominantly early-childhood onset. Affected children display various neurological signs, including ataxia and spasticity, and die early. VWM patients have bi-allelic mutations in any of the five genes encoding the subunits of the eukaryotic translation factor 2B (eIF2B). eIF2B regulates protein synthesis rates under basal and cellular stress conditions. The underlying molecular mechanism of how mutations in eIF2B result in VWM is unknown. Previous studies suggest that brain white matter astrocytes are primarily affected in VWM. We hypothesized that the translation rate of certain astrocytic mRNAs is affected by the mutations, resulting in astrocytic dysfunction. Here we subjected primary astrocyte cultures of wild type (wt) and VWM (2b5(ho)) mice to pulsed labeling proteomics based on stable isotope labeling with amino acids in cell culture (SILAC) with an L-azidohomoalanine (AHA) pulse to select newly synthesized proteins. AHA was incorporated into newly synthesized proteins in wt and 2b5(ho) astrocytes with similar efficiency, without affecting cell viability. We quantified proteins synthesized in astrocytes of wt and 2b5(ho) mice. This proteomic profiling identified a total of 80 proteins that were regulated by the eIF2B mutation. We confirmed increased expression of PROS1 in 2b5(ho) astrocytes and brain. A DAVID enrichment analysis showed that approximately 50% of the eIF2B-regulated proteins used the secretory pathway. A small-scale metabolic screen further highlighted a significant change in the metabolite 6-phospho-gluconate, indicative of an altered flux through the pentose phosphate pathway (PPP). Some of the proteins migrating through the secretory pathway undergo oxidative folding reactions in the endoplasmic reticulum (ER), which produces reactive oxygen species (ROS). The PPP produces NADPH to remove ROS. The proteomic and metabolomics data together suggest a deregulation of ER function in 2b5(ho) mouse astrocytes. Frontiers Media S.A. 2017-12-20 /pmc/articles/PMC5770689/ /pubmed/29375313 http://dx.doi.org/10.3389/fncel.2017.00411 Text en Copyright © 2017 Wisse, Penning, Zaal, van Berkel, ter Braak, Polder, Kenney, Proud, Berkers, Altelaar, Speijer, van der Knaap and Abbink. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Wisse, Lisanne E.
Penning, Renske
Zaal, Esther A.
van Berkel, Carola G. M.
ter Braak, Timo J.
Polder, Emiel
Kenney, Justin W.
Proud, Christopher G.
Berkers, Celia R.
Altelaar, Maarten A. F.
Speijer, Dave
van der Knaap, Marjo S.
Abbink, Truus E. M.
Proteomic and Metabolomic Analyses of Vanishing White Matter Mouse Astrocytes Reveal Deregulation of ER Functions
title Proteomic and Metabolomic Analyses of Vanishing White Matter Mouse Astrocytes Reveal Deregulation of ER Functions
title_full Proteomic and Metabolomic Analyses of Vanishing White Matter Mouse Astrocytes Reveal Deregulation of ER Functions
title_fullStr Proteomic and Metabolomic Analyses of Vanishing White Matter Mouse Astrocytes Reveal Deregulation of ER Functions
title_full_unstemmed Proteomic and Metabolomic Analyses of Vanishing White Matter Mouse Astrocytes Reveal Deregulation of ER Functions
title_short Proteomic and Metabolomic Analyses of Vanishing White Matter Mouse Astrocytes Reveal Deregulation of ER Functions
title_sort proteomic and metabolomic analyses of vanishing white matter mouse astrocytes reveal deregulation of er functions
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770689/
https://www.ncbi.nlm.nih.gov/pubmed/29375313
http://dx.doi.org/10.3389/fncel.2017.00411
work_keys_str_mv AT wisselisannee proteomicandmetabolomicanalysesofvanishingwhitemattermouseastrocytesrevealderegulationoferfunctions
AT penningrenske proteomicandmetabolomicanalysesofvanishingwhitemattermouseastrocytesrevealderegulationoferfunctions
AT zaalesthera proteomicandmetabolomicanalysesofvanishingwhitemattermouseastrocytesrevealderegulationoferfunctions
AT vanberkelcarolagm proteomicandmetabolomicanalysesofvanishingwhitemattermouseastrocytesrevealderegulationoferfunctions
AT terbraaktimoj proteomicandmetabolomicanalysesofvanishingwhitemattermouseastrocytesrevealderegulationoferfunctions
AT polderemiel proteomicandmetabolomicanalysesofvanishingwhitemattermouseastrocytesrevealderegulationoferfunctions
AT kenneyjustinw proteomicandmetabolomicanalysesofvanishingwhitemattermouseastrocytesrevealderegulationoferfunctions
AT proudchristopherg proteomicandmetabolomicanalysesofvanishingwhitemattermouseastrocytesrevealderegulationoferfunctions
AT berkersceliar proteomicandmetabolomicanalysesofvanishingwhitemattermouseastrocytesrevealderegulationoferfunctions
AT altelaarmaartenaf proteomicandmetabolomicanalysesofvanishingwhitemattermouseastrocytesrevealderegulationoferfunctions
AT speijerdave proteomicandmetabolomicanalysesofvanishingwhitemattermouseastrocytesrevealderegulationoferfunctions
AT vanderknaapmarjos proteomicandmetabolomicanalysesofvanishingwhitemattermouseastrocytesrevealderegulationoferfunctions
AT abbinktruusem proteomicandmetabolomicanalysesofvanishingwhitemattermouseastrocytesrevealderegulationoferfunctions